A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response

Background: B-cells have been suggested to play a role in the pathogenesis of systemic sclerosis (SSc), representing, therefore, a potential therapeutic target. Objectives: We aimed at investigating the 36-month outcomes of 20 SSc patients who underwent an intensified B-depletion therapy (IBCDT) sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Daniela, Sciascia, Savino, Cecchi, Irene, Saracco, Marta, Montabone, Erika, Modena, Vittorio, Pellerito, Raffaele, Carignola, Renato, Roccatello, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830314/
https://www.ncbi.nlm.nih.gov/pubmed/33466837
http://dx.doi.org/10.3390/jcm10020292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830314/
https://www.ncbi.nlm.nih.gov/pubmed/33466837
http://dx.doi.org/10.3390/jcm10020292

Ejemplares similares